Oncoinvent Names New Chief Medical Officer

MT Newswires · 5d ago
02:53 AM EDT, 10/28/2026 (MT Newswires) -- Biotechnology company Oncoinvent (ONCIN.OL) appointed Zuzana Trnková as its new chief medical officer, succeeding Kari Myren, effective Nov. 4. Trnková most recently served as chief medical officer at clinical-stage biotechnology company Highlight Therapeutics, according to a Wednesday release.